Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (1289)	12/12/2002 9:58:43 AM
From: tuck	Respond to of 1784

MDS reports. Going to spare y'all the numbers -- in part because they are hard to format -- as you can find them yourselves if you care that much. >>TORONTO, Dec. 12 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS, NYSE: MDZ) today reported strong performance in its fourth quarter ended October 31, 2002. Operating income grew 20% from $41 million in the fourth quarter of 2001 to $49 million in the fourth quarter of 2002. Revenues increased by 11% to $475 million. Basic earnings per share increased 20% from $0.15 in the fourth quarter of 2001 to $0.18 in the same period this year. Earnings per share from core businesses, which include the Life Sciences and Health segments and exclude non-recurring items, grew 42% to $0.27 compared to $0.19 in the fourth quarter of 2001. Revenues grew 10% to $1,792 million in 2002 from $1,636 million in 2001. Operating income grew to $212 million from $154 million in the prior year, an increase of 38%. A table comparing the components of earnings, year over year, is included later in this release. "I am pleased with the fourth consecutive quarter of growth at MDS." said John Rogers, MDS President and CEO. "Our businesses continue to deliver on their plans; in particular MDS Pharma Services and MDS Sciex who performed exceptionally well," he added.<< snip Cheers, Tuck